Cargando…
The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal hae...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779802/ https://www.ncbi.nlm.nih.gov/pubmed/33408501 http://dx.doi.org/10.2147/IJNRD.S285168 |
_version_ | 1783631402192863232 |
---|---|
author | Hsu, Hon-Chun Robinson, Chanel Norton, Gavin R Woodiwiss, Angela J Dessein, Patrick H |
author_facet | Hsu, Hon-Chun Robinson, Chanel Norton, Gavin R Woodiwiss, Angela J Dessein, Patrick H |
author_sort | Hsu, Hon-Chun |
collection | PubMed |
description | INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal haemoglobin target depends on its opposing effects on arterial stiffness and pressure pulsatility in CKD. METHODS: Arterial stiffness (aortic pulse wave velocity), wave reflection (augmentation index, reflected wave pressure and reflection magnitude), and pressure pulsatility (central systolic and pulse pressure, peripheral pulse pressure, pressure amplification and forward wave pressure) were assessed in 48 dialysis patients. RESULTS: In established confounder and diabetes adjusted linear regression models, haemoglobin levels were directly associated with arterial stiffness (partial R=0.366, p=0.03) and inversely with central systolic pressure (partial R=−0.344, p=0.04), central pulse pressure (partial R=−0.403, p=0.01), peripheral pulse pressure (partial R=−0.521, p=0.001) and forward wave pressure (partial R=−0.544, p=0.001). The presence of heart failure and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and erythropoietin stimulating agents did not materially alter these relationships upon further adjustment for the respective characteristics in the models, and in sensitivity analyses. In receiver operator characteristic curve analysis, the optimal haemoglobin concentration cut-off values in predicting arterial stiffness and increased central pulse pressure were remarkably similar at 10.95 g/dl and 10.85 g/dl, respectively, and with clinically useful sensitivities, specificities and positive and negative predictive values. In logistic regression models, a haemoglobin value of >10.9 mg/dl was associated with both arterial stiffness (>10 m/sec; OR (95% CI) = 10.48 (1.57–70.08), p=0.02) and normal central pulse pressure (>50 mmHg; OR (95% CI) = 7.55 (1.58–36.03), p=0.01). CONCLUSION: This study suggests that the optimal haemoglobin target in dialysis patients is ~11g/dl and determined by its differential and contrasting effects on arterial stiffness and pressure pulsatility. |
format | Online Article Text |
id | pubmed-7779802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77798022021-01-05 The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility Hsu, Hon-Chun Robinson, Chanel Norton, Gavin R Woodiwiss, Angela J Dessein, Patrick H Int J Nephrol Renovasc Dis Original Research INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal haemoglobin target depends on its opposing effects on arterial stiffness and pressure pulsatility in CKD. METHODS: Arterial stiffness (aortic pulse wave velocity), wave reflection (augmentation index, reflected wave pressure and reflection magnitude), and pressure pulsatility (central systolic and pulse pressure, peripheral pulse pressure, pressure amplification and forward wave pressure) were assessed in 48 dialysis patients. RESULTS: In established confounder and diabetes adjusted linear regression models, haemoglobin levels were directly associated with arterial stiffness (partial R=0.366, p=0.03) and inversely with central systolic pressure (partial R=−0.344, p=0.04), central pulse pressure (partial R=−0.403, p=0.01), peripheral pulse pressure (partial R=−0.521, p=0.001) and forward wave pressure (partial R=−0.544, p=0.001). The presence of heart failure and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and erythropoietin stimulating agents did not materially alter these relationships upon further adjustment for the respective characteristics in the models, and in sensitivity analyses. In receiver operator characteristic curve analysis, the optimal haemoglobin concentration cut-off values in predicting arterial stiffness and increased central pulse pressure were remarkably similar at 10.95 g/dl and 10.85 g/dl, respectively, and with clinically useful sensitivities, specificities and positive and negative predictive values. In logistic regression models, a haemoglobin value of >10.9 mg/dl was associated with both arterial stiffness (>10 m/sec; OR (95% CI) = 10.48 (1.57–70.08), p=0.02) and normal central pulse pressure (>50 mmHg; OR (95% CI) = 7.55 (1.58–36.03), p=0.01). CONCLUSION: This study suggests that the optimal haemoglobin target in dialysis patients is ~11g/dl and determined by its differential and contrasting effects on arterial stiffness and pressure pulsatility. Dove 2020-12-30 /pmc/articles/PMC7779802/ /pubmed/33408501 http://dx.doi.org/10.2147/IJNRD.S285168 Text en © 2020 Hsu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Hsu, Hon-Chun Robinson, Chanel Norton, Gavin R Woodiwiss, Angela J Dessein, Patrick H The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title | The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title_full | The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title_fullStr | The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title_full_unstemmed | The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title_short | The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility |
title_sort | optimal haemoglobin target in dialysis patients may be determined by its contrasting effects on arterial stiffness and pressure pulsatility |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779802/ https://www.ncbi.nlm.nih.gov/pubmed/33408501 http://dx.doi.org/10.2147/IJNRD.S285168 |
work_keys_str_mv | AT hsuhonchun theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT robinsonchanel theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT nortongavinr theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT woodiwissangelaj theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT desseinpatrickh theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT hsuhonchun optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT robinsonchanel optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT nortongavinr optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT woodiwissangelaj optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility AT desseinpatrickh optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility |